ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Heart transplant patients"

  • 2019 American Transplant Congress

    Could Intravenous Iron Strengthen The Chances Of Heart Transplantation For Patients With Left Ventricular Assist Devices?

    A. Mardis1, C. Mardis2, J. Barham3, A. Poole3, S. Branham3, R. Napier4, J. Martin3, P. McCann4

    1Department of Pharmacy, Palmetto Health, Columbia, SC, 2Clinical Pharmacy and Outcomes Sciences, University of South Carolina, Columbia, SC, 3Cardiothoracic Surgery, Palmetto Health, Columbia, SC, 4Cardiology, Palmetto Health, Columbia, SC

    *Purpose: Iron deficiency anemia (IDA) is prevalent in patients supported by left ventricular assist devices (LVADs), is associated with functional limitations, and often warrants blood…
  • 2019 American Transplant Congress

    Pictogram Tool to Improve Medication Adherence in Heart Transplant Families with Limited English Proficiency and Low Health Literacy

    A. C. Rothkopf1, J. Chen2, N. Jasiak-Panek3, K. Le3, A. Joong4, L. J. Addonizio1

    1Pediatric Cardiology, Columbia University, New York, NY, 2Department of Pharmacy, Columbia University, New York, NY, 3Department of Pharmacy, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 4Pediatric Cardiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL

    *Purpose: Rejection in heart transplant recipients significantly limits long-term survival, impairs quality of life, and increases both direct and indirect costs of care. Preventing rejection…
  • 2019 American Transplant Congress

    A Comprehensive and Updated Analysis of Combined Heart-Kidney Transplants Utilizing the United Network for Organ Sharing Database

    V. M. Lim1, N. Khurmi1, W. R. Hewitt, Jr.2, A. K. Mathur2, O. E. Pajaro3, D. E. Jaroszewski3, B. D. Gaitan1

    1Anesthesiology, Mayo Clinic Arizona, Phoenix, AZ, 2Transplantation Surgery, Mayo Clinic Arizona, Phoenix, AZ, 3Cardiovascular and Thoracic Surgery, Mayo Clinic Arizona, Phoenix, AZ

    *Purpose: Analysis of combined heart-kidney transplants (HKTx) reveals equivalent or improved patient survival and reduced allograft rejection rates as compared to single-organ transplants. The rate…
  • 2019 American Transplant Congress

    Impact of HLA Mismatches and Cytomegalovirus Seropositivity on Outcomes Following Heart Transplantation

    A. Singhvi, R. Araujo-Gutierrez, M. H. Park, A. Bhimaraj, B. H. Trachtenberg, I. Hussain, A. Guha

    Division of Cardiology/ JC Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX

    *Purpose: Cytomegalovirus (CMV) infection is associated with the development of cardiac allograft vasculopathy (CAV). CAV is one of the leading causes of death and graft…
  • 2019 American Transplant Congress

    Caregiving in Thoracic Transplantation–A SR/MA

    A. A. Rmilah, J. Lau, R. Mendpara, P. Erwin, C. C. Kennedy

    Mayo Clinic, Rochester, MN

    *Purpose: Caregivers are required for heart and lung transplantation, however, little emphasis is placed on the pre-transplant caregiving experience. Our objective was to perform a…
  • 2019 American Transplant Congress

    Donors and Drugs: How Often Do They Mix? Utilization of Donors Based on Toxicology Findings

    J. T. Lansinger1, A. Long1, C. Barreiro2, J. M. Herre2, H. Copeland3, W. Old2, G. Zeevi2, C. D. Kemp2, J. M. Philpott2, K. Stelling2, A. Ingemi2, B. H. Smith2, P. Bourassa2, D. A. Baran2

    1Eastern Virginia Medical School, Norfolk, VA, 2Sentara Heart Hospital, Norfolk, VA, 3Division of Cardiothoracic Surgery, University of Mississippi Medical Center, Jackson, MS

    *Purpose: Despite an increasing number of patients waiting for heart transplantation, the growth of transplant volume has risen slowly. The opioid crisis has resulted in…
  • 2019 American Transplant Congress

    Rejection, Infectious, and Renal Outcomes with Perioperative Desensitization in Orthotopic Heart Transplant Recipients

    M. Plazak, B. Reed, S. Hammad, S. Gale, V. Ton, D. Kaczorowski, T. Trobiano, B. Ravichandran

    University of Maryland Medical Center, Baltimore, MD

    *Purpose: Pre-transplant allosensitization remains a significant barrier to organ allocation and a paucity of evidence exists to demonstrate the efficacy and safety of perioperative desensitization…
  • 2019 American Transplant Congress

    Willingness to Acquire Donor-Derived Hepatitis C Infection May Reduce Waitlist Mortality for Heart Transplant Candidates

    B. E. Lonze, A. Reyentovich, N. Moazami, D. E. Smith, C. Gidea, R. A. Montgomery

    NYU Langone Transplant Institute, New York, NY

    *Purpose: Hearts from deceased donors with hepatitis C infection (HCV+) are disproportionately discarded because most waitlist registrants are HCV negative (HCV-). For some with end-organ…
  • 2019 American Transplant Congress

    Geographic Disparities in Heart Transplant Rates

    M. Kosztowski, S. Yu, A. Kilic, A. Massie, S. Zhou, D. Segev, S. Gentry

    JHU, Baltimore, MD

    *Purpose: One of the motivations for the recent changes to the heart allocation policy was to reduce geographic disparities. We investigated whether heart transplant (HT)…
  • 2019 American Transplant Congress

    Reference Ranges Donor-Derived Cell-Free DNA in a Heart Transplant Population

    A. Kao1, S. Dholakia2, M. Deng3

    1Saint Luke's, Kansas City, MO, 2CareDx, Brisbane, CA, 3University of Los Angeles, Los Angeles, CA

    *Purpose: Elevations in donor-derived cell-free DNA (dd-cfDNA) ≥0.20 % in heart transplant recipients (HTR) has been shown to be associated with a probability of acute…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 30
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences